Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(10%)
Results Posted
33%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
8
80%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Terminated1
Not yet recruiting1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (10.0%)
Phase 41 (10.0%)
N/A8 (80.0%)

Trials by Status

completed660%
terminated110%
not_yet_recruiting110%
recruiting110%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10